The global ablation devices market is estimated to grow at a CAGR of 11.65% during the forecast period from 2022 to 2027.

The global ablation devices market is estimated to grow at a CAGR of 11.65% during the forecast period from 2022 to 2027. Factors such as the increasing incidence of cancers such as liver cancer, the rising prevalence of chronic pains such as musculoskeletal pains, the rising prevalence of cardiac arrhythmia such as atrial fibrillation, and the rising regulatory approvals for technologically advanced ablation devices. Therefore, the market for ablation devices is estimated to grow at a significant CAGR during the forecast period from 2022 to 2027.

Ablation Devices Overview
Ablation systems use heat or cold to cause small burns due to these lesions scar tissues are created that block electrical signals causing arrhythmia. Heat is usually generated by radiofrequency, energy, or laser.

Download Sample Report- https://www.delveinsight.com/sample-request/ablation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Regions covered in the report
• Global

Recent Developmental Activities in the Ablation Devices Market:
• In December 2021, BD, the largest global medical technology company, announced that it has acquired Venclose, a medical technology company and its solutions for treating chronic venous insufficiency (CVI), such as radio frequency (RF) ablation technology, with its catheters potentially reducing post-operative pain
• In July 2020, Ethicon, a part of the Johnson & Johnson Medical Devices Company, announced FDA has granted Breakthrough Device Designation for transbronchial microwave ablation technology using robotic-assisted bronchoscopy in the US, it provides a minimally invasive option for soft tissue lesions.
• In February 2019, Medtronic, a global leader in medical technology, launched the new Accurian radiofrequency ablation system in the US, following 510(k) clearance from the country's regulatory authority, radiofrequency ablation involves radio waves-generated current that heats a small portion of nerve tissue to prevent sending of pain signals and thus reduces pain.

Key Takeaways from the Ablation Devices Market Report Study:
• Market size analysis for the current ablation devices market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ablation devices market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global ablation devices market.
• Various opportunities are available for the other competitors in the ablation devices market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027.
• Which are the top-performing regions and countries in the current ablation devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for ablation devices market growth in the coming future?

COVID19 Impact on the Ablation Devices Market
Additionally, the ongoing COVID-19 pandemic has negatively impacted the ablation devices market. The nationwide lockdown in almost every country, restricted the movement of people, supply chains & logistics were halted, unavailability of the workforce at the production sites hampered the manufacturing process due to which there was product shortage in the market, and elective surgeries were also postponed and not given priority as COVID-19 patients were given more preference in terms of treatment. Ablation procedures are the treatment options used in elective surgeries such as cardiovascular, cancers, and other surgeries which were also postponed. For instance, as per the American Hospital Association 2020, between March and June 2020, there had been an estimated loss of USD 50.7 billion to United States hospitals as a result of the reduction observed in "elective" procedures. As per the same source, on average these procedures accounted for about 31% of the net revenue in the United States. However, with masses being vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, & manufacturing units, and an increase in elective surgeries, the ablation devices market has picked momentum again and is expected to further grow during the forecast period (2022-2027)

Ablation Devices Market Dynamics
One of the most prominent factors driving the demand for ablation devices is the increasing incidence of various cancers such as liver cancer. According to the Centers for Disease Control and Prevention (CDC) published data in the year 2021, each year in the United States, around 25,000 men and 11,000 women suffer from liver cancer. Therefore, ablation devices can be used for the treatment of liver cancer by destroying liver tumors, this will increase the demand for ablation devices, thereby increasing the growth of the overall ablation devices market growth during the forecast period (2022-2027).

Ablation Devices Market Segment Analysis
• Ablation Devices Market by Technology (Radiofrequency, Thermosphere, Microwave, Cryoablation, Ultrasonic, and Others)
• Ablation Devices Market by Application (Cardiovascular, Oncology, Gynaecology, Orthopaedic, and Others)
• Ablation Devices Market by End-User (Hospitals, Ambulatory Surgical Centers, and Others),
• Ablation Devices Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Ablation Devices Market Companies
Some of the key market players operating in the ablation devices market include Medtronic, AngioDynamics, ATRICURE INC, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, OLYMPUS CORPORATION, Ethicon (Johnson & Johnson Services, Inc), Abbott, CONMED Corporation, Smith & Nephew, BD, Varian Medical Systems Inc, Hologic Inc, Stryker, Japan Lifeline Co Ltd, Merit Medical Systems, Integra LifeSciences, Terumo Europe NV, and others.

Ablation Devices Market Growth
One of the key supporting factors for the growth of the North America ablation devices market is the rising prevalence of cardiac arrhythmia such as atrial fibrillation. As per Centers for Disease Control and Prevention (CDC) data published in the year 2021, it was estimated that by the year 2030, there will be 12.1 million cases of atrial fibrillation in the United States. Thus, ablation devices are required to treat people suffering from atrial fibrillation. Therefore, the rising prevalence of cardiac arrhythmia such as atrial fibrillation can increase the demand for ablation devices, thereby contributing to the overall growth of the North America ablation devices market.

Request Sample Report- https://www.delveinsight.com/sample-request/ablation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Ablation Devices Market Report Introduction
2. Ablation Devices Market Executive Summary
3. Regulatory and Patent Analysis
4. Ablation Devices Market Key Factors Analysis
5. Ablation Devices Market Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Ablation devices Market
7. Ablation Devices Market Layout
8. Ablation Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Do you have any query related to the report? If yes, visit here- https://www.delveinsight.com/report-store/ablation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.